Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study.
John SpiliotisChristos R IavazzoAlexandros FotiouNikolaos KopanakisAlexios TerraElias EfstathiouCharalambia MargariMarinos TsiatasPublished in: Journal of surgical oncology (2020)
The treatment of advanced ovarian cancer patients with upfront cytoreductive surgery plus HIPEC is feasible with the same survival results. Further, larger prospective studies need to verify our results.
Keyphrases